FDA Investigator Adalberto Cajigas
Adalberto Cajigas has inspections in 1 countries as of 23 Nov 2022. Adalberto Cajigas has collaborated with a combined 1426 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
23 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adaliz Santaliz Cruz,
Ann L Demarco,
Annette Melendez,
Ariel Cruz Figueroa,
Arlene M Badillo,
Brenda S Zimmer, PhD,
Cassandra L Abellard,
CDR Ileana Barreto Pettit,
Dayna I Martinez,
Edwin Martinez,
Enrique Galan,
Eva I Merced Medina,
Fredrick L Fricke,
German Rivera,
Hector J Colon Torres,
Hristu B Chepa,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
Jaime E Pares,
Javier O Vega,
Jennifer D Hollstrom,
Jennifer L Huntington,
Jennifer Lalama,
Joanne E King,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Cruz,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose R Lopez,
Jose Velez,
Karen A Wolnik,
Karl D Hezel,
Laiza V Garcia,
Laura E Garcia,
LCDR Michael H Tollon,
Libia M Lugo,
Lourdes Andujar,
LT Kimberly M Hull,
LT Rafael Gonzalez,
LT Tamara J Henderson,
Margarita Santiago,
Marian E Ramirez,
Marianela Aponte Cruz,
Maridalia Torres,
Maridalia Torres Irizarry,
Michelle Y Clark Stuart,
Miguel A Martinez,
Miguel Hernandez Sanchez,
Min Tang,
Muralidhara B Gavini, PhD,
Noreen Muniz,
Pablo Feliciano,
Patrick C Klotzbuecher,
Rafael Nevarez,
Rafael Nevarez Nieves,
Rakhi B Shah,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Robert Sharpnack,
Rosa J Motta,
Rozelle G Smith,
Sonia M Monges,
Steven B Barber,
Steven P Donald,
Teresa I Navas,
Thomas J Arista,
Wanda J Torres,
Xiujing L Baggett,
Youmin Wang
Adalberto Cajigas's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2009 | FDA 483 | TAPI Puerto Rico, Inc. - Form 483, 2009-08-06 |
June, 2010 | FDA 483 | Bristol-Myers Squibb Manufacturing Company Unlimited Company - Form 483, 2010-06-25 |
September, 2007 | FDA 483 | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2007-09-07 |
September, 2008 | FDA 483 | Teva Puerto Rico LLC - Form 483, 2008-09-15 |
June, 2009 | FDA 483 | Pace Analytical, Inc - Form 483, 2009-06-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more